Deepak Nitrite’s Q4 FY26 rebound shows what integration can protect
Ask Iris
/**
- Title: Deepak Nitrite Q4 FY26: Margin rebound, integration push, and a June 2028 polycarbonate target */
Deepak Nitrite Q4 FY26: Margin rebound, integration push, and a June 2028 polycarbonate target
Deepak Nitrite closed FY26 with a sharp sequential recovery in Q4, even as the full year reflected the pressure of a weak global chemical cycle. Consolidated revenue in Q4 FY26 stood at 2,127 crore, up 7 percent quarter on quarter but down 3 percent year on year. The bigger swing came from profitability. EBITDA rose to 383 crore, up 74 percent sequentially, and EBITDA margin improved to 18 percent from 11 percent in Q3 FY26. Profit after tax came in at 220 crore, up 120 percent quarter on quarter and 9 percent year on year.
For FY26, however, consolidated revenue fell to 7,947 crore versus 8,366 crore in FY25. EBITDA declined to 1,041 crore from 1,176 crore, and PAT dropped to 551 crore from 697 crore. Management described the year as one marked by supply chain disruptions, geopolitical volatility, and pricing pressure across chemical value chains. The Q4 bounce was attributed to stable volumes, favorable pricing trends, better plant fungibility, and cost efficiency measures.
Segment performance: Phenolics leads the Q4 rebound
Deepak Nitrite continues to report two primary operating segments in its consolidated disclosure: Advanced Intermediates and Phenolics. In Q4 FY26, Advanced Intermediates revenue from operations was 708 crore, up 8 percent quarter on quarter. Segment EBIT improved to 34 crore from 15 crore in Q3 FY26. Management attributed the improved profitability to product mix optimization, pricing gains relative to raw material costs, and deeper integration leading to greater raw material self-sufficiency.
Phenolics delivered the strongest profit momentum in the quarter. Q4 FY26 revenue from operations stood at 1,429 crore, up 7 percent sequentially, while segment EBIT rose to 287 crore from 145 crore in Q3 FY26. EBIT margin expanded to 20 percent in Q4. Management highlighted pricing gains, stable plant operations, and a recovery in downstream demand from polymer and industrial applications. It also emphasized that debottlenecking and process optimization are ongoing to improve operational flexibility.
On an annual basis, FY26 segment revenue from operations was 2,553 crore for Advanced Intermediates and 5,401 crore for Phenolics, with inter-segment eliminations of 67 crore. This implies Phenolics continued to remain the dominant contributor to consolidated revenue.
Note: Management stated FY26 and Q3 FY26 include exceptional gratuity provision expenses in segmental EBIT disclosures.
Supply chain risk management: procurement discipline and integration
A consistent theme in both the presentation and the conference call was supply chain resilience. The company framed the external environment as disrupted by geopolitical tensions, aggressive global pricing pressure, freight volatility, and feedstock constraints. It also pointed to potential impacts such as raw material uncertainty, margin pressure, demand-supply imbalances, elevated working capital, and lean inventory behavior by customers.
Management described a set of responses centered on feedstock security and structural integration. These included long-term sourcing agreements, supplier diversification, on-site critical input partnerships, and investments in backward integration such as nitric acid, nitration, and hydrogenation.
The call offered one concrete example of procurement behavior. Management said it built higher inventory of critical feedstocks by buying on price dips, anticipating volatility after observing unusual geopolitical developments. According to management, this positioned the company with a reasonable inventory of feedstock at attractive prices going into Q1.
There was also one operational issue that management acknowledged transparently: the nitric acid plant. In response to an analyst question, management said the plant was started but could not run consistently during Q4 due to technical issues, and average utilization was around 45 percent. The company had to source nitric acid from the market to ensure continuity of production and sales. Management said it is working with the technology and equipment suppliers to stabilize operations.
Projects and timelines: MIBK/MIBC in FY27, polycarbonate by June 2028
Deepak Nitrite’s longer-term narrative remains anchored in downstream integration and new chemistries. A major highlight in FY26 was the commissioning and ramp-up of Deepak Chem Tech’s nitration and second hydrogenation plants at Dahej. Management said these were commissioned by the end of Q2 or early Q3 and are operating with expected productivity and efficiency, contributing positively. The company described these projects as improving raw material security, reducing dependency, and enhancing structural cost competitiveness.
Near-term commissioning is expected from the multipurpose agrochemical intermediates and MIBK/MIBC projects. Management stated these are scheduled for commissioning in Q2 FY27. It also indicated mechanical completion is nearing finish and commissioning could occur at the tail end of Q1 or early Q2, as the asset is commissioned alongside other plant assets.
The largest strategic project remains the polycarbonate initiative. The investor presentation positions it as India’s first integrated polycarbonate plant with capacity of 165,000 MT per year, aimed at building an integrated chain from Cumene to Phenol to Acetone and then to Polycarbonate. The company provided execution updates: dismantling of equipment in Stade, Germany is progressing with shipments already underway, infrastructure and contractor mobilization in India has begun, and ordering for multiple equipment, including boilers, has commenced.
A key enabler discussed was the HyCO agreement. Deepak Chem Tech signed a long-term agreement with Praxair India (Linde) to set up a dedicated on-site HyCO plant under a Build-Own-Operate model. Management positioned this as improving supply chain security for critical raw materials and enhancing execution visibility. It stated that commissioning is targeted in 2028, aligned with the polycarbonate timeline.
On funding, management said the total announced project outlay across projects is around 11,000 crore, and funding is planned in a 60:40 debt-equity mix with bank tie-ups in place. It stated equity infusion has started and debt drawdowns will begin once equity conditions are met.
What management is signaling for FY27
While the company did not provide a numerical earnings or revenue guidance for FY27, management made several directional statements. It said Q1 is expected to be better than Q4 on both standalone and consolidated basis. It also stated that FY27 should show an improving trend and a stronger margin profile compared to FY26, supported by new products and higher margin accretive downstream additions.
The call also discussed developments in China related to safety and compliance audits across hazardous chemistries. Management said these developments have already started and could act as a structural tailwind for responsible manufacturers. At the same time, it flagged a global headwind in sulfur downstream costs, including sulfuric acid and related inputs, indicating continued input cost volatility.
Takeaways
Deepak Nitrite’s Q4 FY26 showed what operational stability, procurement discipline, and product mix agility can deliver in a volatile cycle. The year-on-year decline in FY26 earnings underscores that the broader chemical environment remains challenging, but the quarter suggests earnings power can re-emerge when spreads and execution align.
The next set of investor checkpoints are clearer on timelines than on near-term numbers. MIBK/MIBC and agro intermediates are slated for commissioning in Q2 FY27, while the polycarbonate program is targeted for commissioning by June 2028, supported by HyCO feedstock security and ongoing equipment relocation and ordering.
In the interim, management’s emphasis remains consistent: deepen integration, strengthen supply resilience, and push forward into higher value downstream products while keeping cost competitiveness intact.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
